Status
Conditions
Treatments
About
In this prospective observational sub-study, participants with pediatric-onset hypophosphatasia (HPP) (perinatal/infantile- or juvenile-onset) of any age will be followed for a minimum of 5 years at sites in the United States and potentially 1 or 2 other countries.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 1 patient group
Loading...
Central trial contact
Alexion Pharmaceuticals, Inc. (Sponsor)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal